Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Enzyme replacement therapy in Anderson-Fabry's disease: beneficial clinical effect on vital organ function.

De Schoenmakere G, Chauveau D, Grünfeld JP.

Nephrol Dial Transplant. 2003 Jan;18(1):33-5.

PMID:
12480957
2.

Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.

Mignani R, Cagnoli L.

J Nephrol. 2004 May-Jun;17(3):354-63. Review.

PMID:
15365954
3.

[Effect of enzyme replacement therapy (ERT) on renal function of patients with Fabry's disease].

Thomaidis T, Relle M, Reinke J, Beck M, Schwarting A.

Med Klin (Munich). 2009 Sep 15;104(9):699-703. doi: 10.1007/s00063-009-1152-1. Epub 2009 Sep 23. Review. German.

PMID:
19779674
4.

[Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients].

Cianciaruso B, Pisani A, Andreucci MV, Parente N, Andria G, Federico S, Sabbatini M, Sessa A.

G Ital Nefrol. 2003 Mar-Apr;20(2):113-9. Review. Italian.

PMID:
12746795
5.

Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment.

Mahmud HM.

J Pak Med Assoc. 2014 Feb;64(2):189-94. Review.

6.

[Renal involvement in Fabry's disease: diagnosis, follow-up and enzyme replacement therapy].

Mignani R, Feriozzi S, Carraro G, Martinelli F, Cianciaruso B.

G Ital Nefrol. 2009 Sep-Oct;26(5):577-84. Review. Italian.

PMID:
19802803
7.

A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.

Connock M, Juarez-Garcia A, Frew E, Mans A, Dretzke J, Fry-Smith A, Moore D.

Health Technol Assess. 2006 Jun;10(20):iii-iv, ix-113. Review.

8.

Current enzyme replacement therapy for the treatment of lysosomal storage diseases.

Lim-Melia ER, Kronn DF.

Pediatr Ann. 2009 Aug;38(8):448-55. Review. No abstract available.

PMID:
19725195
9.

Agalsidase alfa--a preparation for enzyme replacement therapy in Anderson-Fabry disease.

Beck M.

Expert Opin Investig Drugs. 2002 Jun;11(6):851-8. Review.

PMID:
12036428
10.

[Fabry's disease. An orphan disease that has found a solution: enzymatic replacement with alpha-galactosidase].

Selgas R, García de Lorenzo A, Valdés F, Beck M.

Nefrologia. 2001 Sep-Oct;21(5):443-7. Review. Spanish. No abstract available.

11.

[Cardiac involvement in Fabry's disease].

Weidemann F, Breunig F.

Med Klin (Munich). 2008 Mar 15;103(3):161-5. doi: 10.1007/s00063-008-1023-1. Review. German.

PMID:
18344066
12.

The heart in Anderson Fabry disease.

Kampmann C, Wiethoff CM, Perrot A, Beck M, Dietz R, Osterziel KJ.

Z Kardiol. 2002 Oct;91(10):786-95. Review.

PMID:
12395219
13.

Fabry disease with special reference to neurological manifestations.

Banerjee TK.

Eur Rev Med Pharmacol Sci. 2004 Nov-Dec;8(6):275-81. Review.

PMID:
15745387

Supplemental Content

Support Center